Thx Pharma SA is a France-based pharmaceutical company specialized in the treatment of rare neurological diseases. The Company is an antisense oligonucleotide platform for the identification and characterization of therapy drug candidates co-constructed with laboratories in the field of neurological diseases. The first drug, TX01 for the disease of Niemann-Pick type C and Gaucher’s disease. The second drug, Batten-1, aims at the form juvenile of Batten disease and could be the first therapy considered in this form. It has marketed its drugs notably in Europe and also in the United States, Canada and Australia.
Health
Sector
Freetrade is your gateway to commission-free investing. Join over 1.6 million users using the Best online trading platform, as voted at the British Bank Awards for six years running.
Freetrade does not provide investment advice and individual investors should make their own decisions or seek independent advice. The value of investments can go down as well as up and you may receive back less than your original investment. Past performance is not a reliable indicator of future returns. Freetrade is a trading name of Freetrade Limited, which is a member firm of the London Stock Exchange and is authorised and regulated by the Financial Conduct Authority. Registered in England and Wales (no. 09797821).
© 2026 Freetrade, All rights reserved. The Apple logo is a trademark of Apple Inc. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.
